DWA
LLY icon

Dorsey Wright & Associates’s Eli Lilly LLY Stock Holding History

Dorsey Wright & Associates’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$562K Sell
468
-40
-8% -$40.9K 0.1% 97
2026
Q1 		$468K Buy
+508
New +$515K 0.06% 142
2025
Q4 		– Sell
-468
Closed -$447K – 99
2025
Q3 		$357K Hold
468
– – 0.08% 113
2025
Q2 		$365K Hold
468
– – 0.09% 113
2025
Q1 		$387K Sell
468
-16,101
-97% -$13.4M 0.1% 108
2024
Q4 		$12.8M Sell
16,569
-2,164
-12% -$1.79M 3.05% 2
2024
Q3 		$16.6M Buy
18,733
+271
+1% +$244K 3.93% 1
2024
Q2 		$16.7M Buy
18,462
+2
+0% +$1.6K 4.34% 1
2024
Q1 		$14.4M Buy
18,460
+2,672
+17% +$1.9M 3.75% 1
2023
Q4 		$9.2M Sell
15,788
-1,056
-6% -$616K 2.8% 1
2023
Q3 		$9.05M Buy
16,844
+431
+3% +$222K 2.81% 1
2023
Q2 		$7.7M Sell
16,413
-417
-2% -$175K 2.32% 2
2023
Q1 		$5.78M Sell
16,830
-5,528
-25% -$1.86M 1.75% 6
2022
Q4 		$8.18M Buy
+22,358
New +$7.93M 2.39% 2
2022
Q2 		$2.5M Buy
7,714
+6,146
+392% +$1.84M 0.73% 71
2022
Q1 		$449K Sell
1,568
-7,418
-83% -$1.91M 0.1% 106
2021
Q4 		$2.48M Sell
8,986
-313
-3% -$79.3K 0.51% 92
2021
Q3 		$2.15M Buy
+9,299
New +$2.3M 0.47% 99
2019
Q3 		– Sell
-2,651
Closed -$294K – 315
2019
Q2 		$294K Sell
2,651
-15,243
-85% -$1.8M 0.07% 122
2019
Q1 		$2.32M Buy
17,894
+2,133
+14% +$259K 0.56% 76
2018
Q4 		$1.82M Buy
+15,761
New +$1.76M 0.55% 77
2015
Q4 		– Sell
-5,158
Closed -$432K – 117
2015
Q3 		$432K Buy
+5,158
New +$435K 0.23% 69

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dorsey Wright & Associates's LLY Position: Q2 2026 in Review

Dorsey Wright & Associates reduced its Eli Lilly (LLY) stake by 7.9% in Q2 2026, selling an estimated $40.9K and leaving 468 shares worth $562K. The position accounts for 0.1% of the portfolio, ranked #97.

Dorsey Wright & Associates first reported a position in LLY in Q3 2015 and has held it in 22 quarters since. The position peaked at $16.7M in Q2 2024. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Dorsey Wright & Associates held 468 shares of Eli Lilly worth $562K as of Q2 2026.
  • Dorsey Wright & Associates sold 40 Eli Lilly shares in Q2 2026, an estimated $40.9K.
  • Eli Lilly made up 0.1% of Dorsey Wright & Associates's portfolio in Q2 2026, its #97 holding.
  • Dorsey Wright & Associates first reported a position in Eli Lilly in Q3 2015 and has held it in 22 quarters since.
  • Dorsey Wright & Associates's Eli Lilly position peaked at $16.7M in Q2 2024.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Dorsey Wright & Associates's 13F filing for Q2 2026, filed 6 Aug 2026.